AMERICAN UROLOGICAL ASSOCIATION.

Therapeutic use of antineoplastic agents; Prostate tumors treatment; Urology; Cystectomy; Non-muscle invasive bladder cancer; Prostate-specific antigen; Kidney stones; Conferences & conventions; Transurethral resection of bladder

Nevada; United States

The article discusses the highlights of the American Urological Association's 2025 Annual Meeting held in Las Vegas, Nevada. Topics discussed include the safety and efficacy of cretostimogene in patients with non-muscle invasive bladder cancer, lower prostate-specific antigen response in combination treatment with darolutamide and androgen deprivation therapy, and the efficacy of the CVAC 2.0 system in clearing kidney stones less than 2 cm.